Phase II Trial of Humanized Anti-Lewis Y Monoclonal Antibody for Advanced Hormone Receptor-Positive Breast Cancer That Progressed Following Endocrine Therapy. Clinics 2021, 76, e3146. https://doi.org/10.6061/clinics/2021/e3146.